<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>77-ARIPIPRAZOLE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ARIPIPRAZOLE" rxcui="89013">
<ATC code="N05AX12" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ENZYMATIC INDUCERS" code="N03-J05-001" /></DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations of the aripiprazole</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and possible adjustment of the dosage of the aripiprazole during the administration of these medications together and 1 to 2 weeks after the inducer is stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
